CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 198 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01733368
NCT01733368N/ACompleted

Observational Study to Evaluate the Management of Patients Resynchronized With the QuartetTM LV Quadripolar Lead

Abbott Medical Devices·observational·Posted Nov 27, 2012·Updated Feb 4, 2019

In Brief

An observational study for Heart Failure. Completed, enrolled 198 participants across 1 site.

Detailed Summary

Optimization and evolution of the patient will be evaluated over 6 months after the implant.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsHeart Failure
CountriesSpain
Collaborators--

Timeline

N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedNov 27, 2012
Enrollment StartNov 1, 2012
Primary CompletionAug 1, 2015
Study CompletionAug 1, 2016
TodayJul 2, 2026
Enrollment to primary: 2.8 yearsPosted 13.6 years ago